Complete Genomics (GNOM +0.3%) says that it and BGI-Shenzhen obtained clearance from the Committee on Foreign Investment in the U.S. regarding itI's proposed acquisition of GNOM late Friday. In addition, BGI also extended its all cash offer to purchase all outstanding shares of GNOM until 12:00am ET on Monday, January 7, 2013. The Offer was previously set to expire at 12:00 am ET on Monday, December 31, 2012.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs